Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 11 of 11 for “"Perampanel"”.
-
Efficacy of perampanel in a rat model of hypoxic neonatal serizures
… efficacy of the novel AMPAR-antagonist, perampanel, in suppressing seizures. We also attempt to demonstrate the efficacy of perampanel in reversing seizure-induced post-translational changes to GluR1 and two downstream targets of mTORC1, p70S6 kinase and ribosomal protein S6. However, due …
-
The Evaluation of Perampanel as a Neuroprotective Pharmacotherapy in Traumatic Brain Injury
… This thesis is composed of a study to evaluate Perampanel (PRM), also known as Fycompa ®, and its potential as a neuroprotective agent in TBI. PRM is a selective noncompetitive AMPA receptor antagonist and is approved as an antiepileptic in the United States and Europe. This thesis investigates …
-
Effect of Perampanel or Amantadine Treatment on Pilocarpine Rat Model of Status Epilepticus: Evidence with Seizure Termination, Behavioral Alterations, Epileptogenesis and Neuronal Damage.
… them with pilocarpine. The efficacy of either perampanel, an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor blocker, or amantadine, a N-Methyl-D-aspartic acid (NMDA) receptor blocker, in overcoming pilocrapine-induced SE was assessed using electroencephalogram (EEG) …
-
Efeito do uso de perampanel na capacidade cognitiva de ratos Wistar submetidos à sobrecarga de ferro no período neonatal
… alostérico de receptores AMPA como o fármaco Perampanel (PER), parece agir de maneira favorável contra essa permeabilidade ao cálcio do receptor, porém, o fármaco carece de ensaios moleculares que elucidem seu mecanismo de ação frente a diferentes agressões neuronais. Sendo assim a presente …
-
Novel Neuroprotective Targets of Adenosine and Glutamate Signaling in an Animal Model of Ischemic Stroke
… the potential neuroprotective effects of perampanel, an FDA-approved anti-epileptic drug, which blocks AMPARs in a non-competitive manner. Using in vivo and ex vivo models of ischemic damage, I also investigated the neuroprotective potential of perampanel. This thesis provides evidence of …
-
THE SEPARATE AND SYNERGISTIC EFFECTS OF AMPAR ANTAGONISTS ON THE TRANSITION OF CORTICAL NETWORKS TO EPILEPTIFORM ACTIVITY
… δίαιτας τριγλυκεριδίων μεσαίας αλυσίδας και το perampanel, ένα πρόσφατα εγκεκριμένο αντισπασμωδικό, έχουν αποδειχθεί ότι παρέχουν ισχυρή ανεξάρτητη καθώς και συνεργιστική αντιεπιληπτική δράση μέσω αναστολής των υποδοχέων ΑΜΡΑ. Ωστόσο, δεν είναι ακόμη γνωστό εάν αυτές οι ενώσεις μπλοκάρουν τους …
-
Adenosine Signalling and Regulation of Ca2+-permeable AMPA Receptors in Hypoxia
… the clinically approved anti-seizure drug Perampanel, which is a non-competitive AMPAR antagonist, blocked the generation of APSP. Surprisingly, all CP-AMPAR antagonists tested were effective in preventing hypoxia-induced hippocampal neuronal damage during the early phase of hypoxic …
-
The Extracellular Domains of the AMPA, Kainate, and Orphan Delta Receptor Regulate Channel Gating in Distinct Ways
… of inhibition produced by protonation and perampanel-like drugs. Taken together, this work provides new insights into the distinct roles of the extracellular amino-terminal domain and the agonist-binding domain.